PharmaCyte Biotech (PMCB) Common Equity (2011 - 2026)
PharmaCyte Biotech (PMCB) posted Common Equity of $27.51 million for fiscal Q1 2027 (quarter ended Jul 31, 2026), down 36.9% from $43.59 million a year earlier and down 17.4% from the prior quarter.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Common Equity (2011 - 2026) Analysis & Trends
At the end of FY2026 (ended Apr 30, 2026), PharmaCyte Biotech's Common Equity came in at $33.29 million, down 35.8% from FY2025.
- Annual Common Equity shows a five-year compound annual growth rate of 37.9% (FY2021 to FY2026).
- In prior fiscal years, PharmaCyte Biotech's Common Equity was $51.89 million in FY2025 (+87.7%), $27.65 million in FY2024 (-62.0%), $72.69 million in FY2023 (-19.2%) and $89.92 million in FY2022.
- The fiscal Q1 2027 figure stands as the lowest quarterly Common Equity since fiscal Q1 2022.
- On a year-over-year basis, Common Equity has declined in each of the last five quarters, with growth averaging 3.6% over the last eight quarters.
- The strongest year-over-year quarter for Common Equity in the past five years was fiscal Q4 2025, with growth of 87.7%; the weakest was fiscal Q4 2024, with a decline of 62.0%.
- According to Business Quant data, Common Equity for the three prior fiscal quarters was $33.29 million (Q4 2026), $38.11 million (Q3 2026) and $35.24 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 20.25 Bn |
| 10 | PharmaCyte Biotech | 4.40 Mn | 4.40 Mn | - | 27.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 27.51 Mn |
| Apr 30, 2026 | 33.29 Mn |
| Jan 31, 2026 | 38.11 Mn |
| Oct 31, 2025 | 35.24 Mn |
| Jul 31, 2025 | 43.59 Mn |
| Apr 30, 2025 | 51.89 Mn |
| Jan 31, 2025 | 40.25 Mn |
| Oct 31, 2024 | 43.45 Mn |
| Jul 31, 2024 | 47.71 Mn |
| Apr 30, 2024 | 27.65 Mn |
| Jan 31, 2024 | 31.37 Mn |
| Oct 31, 2023 | 36.77 Mn |
| Jul 31, 2023 | 39.19 Mn |
| Apr 30, 2023 | 72.69 Mn |
| Jan 31, 2023 | 77.12 Mn |
| Oct 31, 2022 | 81.04 Mn |
| Jul 31, 2022 | 86.30 Mn |
| Apr 30, 2022 | 89.92 Mn |
| Jan 31, 2022 | 91.33 Mn |
| Oct 31, 2021 | 92.12 Mn |
API Access
PharmaCyte Biotech Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();